Tech Company Inital Public Offerings
TELA Bio IPO
TELA Bio, based in Malvern, debuted as a public company on 11/7/2019.
Transaction Overview
Company Name
Announced On
11/7/2019
Transaction Type
IPO
Amount
$52,000,000
Proceeds Purpose
We currently intend to use the net proceeds from this offering, together with our existing cash and cash equivalents to hire additional sales and marketing personnel and expand marketing activities to support the ongoing commercialization of our OviTex and OviTex PRS product lines, to fund product development and research and development activities, which may include post-market clinical studies and IDE protocol development for our OviTex PRS products, and the remainder for working capital and general corporate purposes.
Company Information
Company Status
Publicly-held
Industry
Medical Devices & Instruments
Mailing Address
1 Great Valley Pkwy. 24
Malvern, PA 19355
USA
Malvern, PA 19355
USA
Phone
Website
Email Address
Overview
TELA Bio (Nasdaq: TELA), a surgical reconstruction company, is driven by the desire to make a difference. Our seasoned leadership team dedicates their expertise in medical technology to transforming the soft tissue reconstruction market and making natural repair solutions more accessible to patients.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 11/7/2019: Daasity venture capital transaction
Next: 11/8/2019: Nightfall AI venture capital transaction
Share this article
Where The Data Comes From
We document all VC transactions involving tech companies. All VC database entries reported here are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs